🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to compare trastuzumab deruxtecan (T-DXd...
Status
Recruiting
Location
Skåne University Hospital
Start Date
2023-10-26
Trial ID
NCT05900206
Anti-HER2 therapy, such as trastuzumab and pertuzumab, has significantly im...
Status
Active Not Recruiting
Location
Natera
Start Date
2024-04-01
Trial ID
NCT06663787
Treatments Being Tested
ADAPT-HER2-IV will address question of optimal neoadjuvant therapy in patie...
Status
Recruiting
Location
Klinikum Mittelbaden, Brustzentrum
Start Date
2024-02-05
Trial ID
NCT05704829
Treatments Being Tested
This study will look at the efficacy and safety of trastuzumab deruxtecan (...
Status
Active Not Recruiting
Location
Research Site
Start Date
2021-10-25
Trial ID
NCT05113251
Treatments Being Tested
DEMETHER is a phase II trial exploring the maintenance of trastuzumab and p...
Status
Active Not Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2024-07-22
Trial ID
NCT06172127
This study (EXTEND trial) is a multicentre, interventional, prospective, ra...
Status
Not Yet Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2024-09
Trial ID
NCT06548178
The purpose of this study is to further advance the ability to practice per...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2010-03-01
Trial ID
NCT01042379
Treatments Being Tested
This study will evaluate a structured sequential treatment strategy startin...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-04
Trial ID
NCT07683754
Treatments Being Tested
Thie purpose of this study is to find out whether a personalized treatment ...
Status
Recruiting
Location
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Start Date
2026-03-04
Trial ID
NCT07459673
DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-12-28
Trial ID
NCT04538742
Treatments Being Tested